Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring

Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring

Objective/Background: Globally, approximately 50% of patients with multidrug-resistant tuberculosis (MDR-TB) experience treatment failure. MDR-TB treatment is hindered by adverse events, toxicity of the second-line anti-TB drugs, logistics and costs, especially in low-income countries, and problems...

Full description

Bibliographic Details
Main Authors: Mathieu S Bolhuis, Onno W Akkerman, Marieke G.G Sturkenboom, Wiel C.M de Lange, Tjip S van der Werf, Jan-Willem C Alffenaar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Mycobacteriology
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=44;epage=45;aulast=Bolhuis

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=44;epage=45;aulast=Bolhuis

Similar Items